Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Human Molecular Genetics
|
May 31, 2008
RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathology
Mohammad M Ghahramani Seno, Ian R Graham, Takis Athanasopoulos, et al.
Human Gene Therapy
|
June 27, 2008
Human apolipoprotein E expression from mouse skeletal muscle by electrotransfer of nonviral DNA (plasmid) and pseudotyped recombinant adeno-associated virus (AAV2/7)
Vanessa Evans, Helen Foster, Ian R Graham, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 4, 2008
Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transfer
Helen Foster, Paul S Sharp, Takis Athanasopoulos, et al.
Human Gene Therapy
|
April 2, 2011
Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice
Taeyoung Koo, Alberto Malerba, Takis Athanasopoulos, et al.
Current Gene Therapy
|
July 11, 2015
Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)
Klaudia Kawecka, Michael Theodoulides, Yalin Hasoglu, et al.
Atherosclerosis
|
October 22, 2008
Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice
Eyman Osman, Vanessa Evans, Ian R Graham, et al.
Metabolism: Clinical and Experimental
|
June 29, 2010
Adeno-associated virus serotypes 7 and 8 outperform serotype 9 in expressing atheroprotective human apoE3 from mouse skeletal muscle
Vanessa C Evans, Ian R Graham, Takis Athanasopoulos, et al.
Plos One
|
February 8, 2014
Fusion of ubiquitin to HIV gag impairs human monocyte-derived dendritic cell maturation and reduces ability to induce gag T cell responses
Shanthi Herath, Adel Benlahrech, Timos Papagatsias, et al.
Human Gene Therapy
|
October 18, 2021
Success Stories and Challenges Ahead in Hematopoietic Stem Cell Gene Therapy: Hemoglobinopathies as Disease Models
Evangelia Yannaki, Nikoletta Psatha, Anastasia Papadopoulou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 27, 2011
Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes
Manuel A F V Gonçalves, Josephine M Janssen, Quynh G Nguyen, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Human Molecular Genetics
|
May 31, 2008
RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathology
Mohammad M Ghahramani Seno, Ian R Graham, Takis Athanasopoulos, et al.
Human Gene Therapy
|
June 27, 2008
Human apolipoprotein E expression from mouse skeletal muscle by electrotransfer of nonviral DNA (plasmid) and pseudotyped recombinant adeno-associated virus (AAV2/7)
Vanessa Evans, Helen Foster, Ian R Graham, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 4, 2008
Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transfer
Helen Foster, Paul S Sharp, Takis Athanasopoulos, et al.
Human Gene Therapy
|
April 2, 2011
Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice
Taeyoung Koo, Alberto Malerba, Takis Athanasopoulos, et al.
Current Gene Therapy
|
July 11, 2015
Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)
Klaudia Kawecka, Michael Theodoulides, Yalin Hasoglu, et al.
Atherosclerosis
|
October 22, 2008
Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice
Eyman Osman, Vanessa Evans, Ian R Graham, et al.
Metabolism: Clinical and Experimental
|
June 29, 2010
Adeno-associated virus serotypes 7 and 8 outperform serotype 9 in expressing atheroprotective human apoE3 from mouse skeletal muscle
Vanessa C Evans, Ian R Graham, Takis Athanasopoulos, et al.
Plos One
|
February 8, 2014
Fusion of ubiquitin to HIV gag impairs human monocyte-derived dendritic cell maturation and reduces ability to induce gag T cell responses
Shanthi Herath, Adel Benlahrech, Timos Papagatsias, et al.
Human Gene Therapy
|
October 18, 2021
Success Stories and Challenges Ahead in Hematopoietic Stem Cell Gene Therapy: Hemoglobinopathies as Disease Models
Evangelia Yannaki, Nikoletta Psatha, Anastasia Papadopoulou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 27, 2011
Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes
Manuel A F V Gonçalves, Josephine M Janssen, Quynh G Nguyen, et al.
Page
of 3